[(Name of Issuer) Class A Common Stock (Title of Class of Securities) (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A ]
[Execution Version Note Subscription Agreement among Morgancreek Investment Holdings Limited and Mr. Jianyu Yang and Blue Ocean Structure Investment II Company Limited and Blue Ocean Project Fund II, LP Dated February 9, 2017 Table of Contents 1. Interpretations 2 2. The Notes 10 3. 12 4. 14 5.] [Cay]
[Execution Version Note Subscription Agreement among Morgancreek Investment Holdings Limited and Mr. Jianyu Yang and Blue Ocean Structure Investment II Company Limited and Blue Ocean Project Fund II, LP Dated February 9, 2017 Table of Contents 1. Interpretations 2 2. The Notes 10 3. 12 4. 14 5.] [Cay]
[Joint Filing Agreement Remainder of this page is intentionally left blank [ Jianyu Yang Shanghai Hui Fu Science and Technology Development Co., Ltd. Bi Zhang Oakville Holdings Group Limited Cherrylane Investments Limited Zheng Cheng Shanghai Jian Qian Science and Technology Development Co., Ltd.] [E]
[Joint Filing Agreement Remainder of this page is intentionally left blank [ Jianyu Yang Shanghai Hui Fu Science and Technology Development Co., Ltd. Bi Zhang Oakville Holdings Group Limited Cherrylane Investments Limited Zheng Cheng Shanghai Jian Qian Science and Technology Development Co., Ltd.] [E]
[SCHEDULE 13G 2 iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Class of Securities) 45174L108 (CUSIP Number) December 31, 2016 (Date of Ev]
[SCHEDULE 13G 2 iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Class of Securities) 45174L108 (CUSIP Number) December 31, 2016 (Date of Ev]
[iKang Announces Unaudited Financial Results for the Second Quarter Ended September 30, 2016 BEIJING, December 1, 2016 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), the largest provider in Chinas fast growing private preventive healthcare services market ]
[iKang Announces Unaudited Financial Results for the Second Quarter Ended September 30, 2016 BEIJING, December 1, 2016 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), the largest provider in Chinas fast growing private preventive healthcare services market ]
[AMENDMENT NO. 1 TO RIGHTS AGREEMENT EXECUTION VERSION AMENDMENT NO. 1 (this Amendment), dated as of November 28, 2016, to the Rights Agreement (the Rights Agreement), dated as of December 2, 2015, by and between iKang Healthcare Group, Inc., a company incorporated under the laws of the Cayman Is]
